Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mobix Labs Secures AI Drone Contract and Expands into Multi-Billion- Dollar Infrastructure Market
-
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
-
The School Privacy Report Releases Back-to-School Emergency Edition
-
Koryx Announces Updated PEA Results for the Haib Copper Project, Southern Namibia
-
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
-
HPQ Achieves Pilot-Scale Milestone in Commercial Fumed Silica Production, Sets Sights on Higher-Value Market Segment
-
Brunswick Exploration Starts Maiden Drilling Program at Anatacau Main
-
Q2 Metals Increases Drill Activity and Provides Exploration Update on the Cisco Lithium Project in Quebec, Canada
-
Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure
-
Algernon Pharmaceuticals Announces Name Change to Algernon Health
-
Brooge Energy Limited Sets Updated Record Date – Holders must contact brokers to register shares with Continental Stock Transfer & Trust if they are outside the United States and Not U.S. Person
-
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
-
Churchill Resources to Commence Fall Drilling & Trenching Program at the Past-Producing Frost Cove Antimony Mine
-
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)
-
BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)
-
RetailPro, a Nayax Company, and Onebeat Partner to Transform Inventory from Static Data to Real-Time Profit Engine
-
Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia
-
Skye’s CB1 Inhibitor, Nimacimab, Demonstrates Superior Weight Loss and Differentiated Mechanisms from Monlunabant, and Continues to Show Enhanced Combination with Tirzepatide with Durable Post-Trea
-
TappAlpha Expands ETF Lineup with the Innovation 100 Growth & Daily Income ETF (TDAQ)
-
Nusano Announces September Conference Schedule
-
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Hinge Bio Expands Leadership Team to Drive Clinical Development of GEM-DIMER™ Programs and Announces Publication in Scientific Reports
-
Merakris Therapeutics Enrolls 30th Subject in Expanded Access Program of MTX-001; Highlights Clinical Progress at SAWC Fall 2025
-
Sol-Gel Announces Health Canada Approval of EPSOLAY®
-
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai
-
Brooge Energy Limited Sets Updated Record Date – Holders must contact brokers to register shares with Continental Stock Transfer & Trust if they are outside the United States and Not U.S. Persons
-
GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure
-
Aduro Clean Technologies to Participate in September Conferences and Initiates Public Relations Campaign
-
Enthusiast Gaming Announces Major Updates to Iconic Addicting Games Platform
-
G-III Apparel Group, Ltd. Reports Second Quarter Fiscal 2026 Results; Provides Updated Fiscal 2026 Outlook
-
Walden Biosciences Announces Key Initiatives to Advance Clinical Pipeline and Support Phase 2 Program for WAL0921 in Rare Kidney Diseases
-
Regenx Provides Bi-Weekly Update on Status of Management Cease Trade Order
-
Helium Evolution Provides Operations Update
-
TappAlpha Expands ETF Lineup with the Innovation 100 Growth & Daily Income ETF (TDAQ)
-
Cancer Focus Fund Appoints Distinguished Industry Experts David R. Epstein and Michael Margolis as Advisors to Its Investment Committee
-
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
-
Experience Out-of-this-world Flavor with incredibles Strawberry Supernova Comets
-
Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer
-
Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
-
Inventus Discovers New Gold-Bearing Channel With Thickest Intercept to Date at the Pardo Gold Project
-
Breckenridge Distillery and Denver Broncos Kick Off Fifth Year of Partnership with New Lineup of Spirits, Including Limited-Edition Broncos Honey Whiskey
-
C4 Therapeutics Highlights Recent Achievement in Biogen Collaboration
-
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
-
NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
OTC Markets Group Welcomes Verusa Holding Anonim Sirketi to OTCQX
-
Immunocore to present at upcoming investor conferences
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Symphonim Nexus Alliance Strengthens Regional Presence with Landmark Community Event in Vietnam
-
Nano Banana AI - The Ultimate Tool to Edit Images Like a Pro
